Form 8-K - Current report:
SEC Accession No. 0001753926-24-001793
Filing Date
2024-11-01
Accepted
2024-11-01 17:00:39
Documents
14
Period of Report
2024-11-01
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K g084523_8k.htm   iXBRL 8-K 34173
2 EX-99.1 g084523_ex99-1.htm EX-99.1 7634
  Complete submission text file 0001753926-24-001793.txt   222379

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE lipo-20241101.xsd EX-101.SCH 3012
4 XBRL LABEL FILE lipo-20241101_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE lipo-20241101_pre.xml EX-101.PRE 24163
16 EXTRACTED XBRL INSTANCE DOCUMENT g084523_8k_htm.xml XML 3857
Mailing Address 400 N LEXINGTON ST STE LL103 PITTSBURGH PA 15208
Business Address 400 N LEXINGTON ST STE LL103 PITTSBURGH PA 15208 412-901-0315
LIPELLA PHARMACEUTICALS INC. (Filer) CIK: 0001347242 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41575 | Film No.: 241419866
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)